REPL- Replimune Group, Inc.

Name: Replimune Group, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Replimune Group, Inc. (REPL) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. REPL is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Astley-Sparke Philip	1.43M	$5.51M	-
CEO	Patel Sushil	533.6K	$2.06M	-
Other	Xynos Konstantinos	199.7K	$769.8K	-
CFO	Hill Emily Luisa	194.4K	$749.3K	-
Other	Schwendenman Andrew	78.3K	$301.8K	-

Activity

Buys and sells only

Transactions

10 filings · page 5

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 16, 2022	Esposito Pamela75	Chief Business Officer	Sell	3,507	$14.59	$51,167.13	-1.5%	+42.1%	+27.3%
May 16, 2022	Franchi Jean M.46	Chief Financial Officer	Sell	3,436	$14.59	$50,131.24	-3.5%	+42.1%	+27.3%
May 16, 2022	Lewis Tanya54	Chief Dev. Op Officer	Sell	5,473	$14.59	$79,851.07	-4.3%	+42.1%	+27.3%
May 16, 2022	Patel Sushil64	Chief Commercial Officer	Sell	10,687	$14.59	$155,923.33	-7.6%	+42.1%	+27.3%
May 16, 2022	Coffin Robert61	President &Chief R&D Officer	Sell	5,737	$14.59	$83,702.83	-0.3%	+42.1%	+27.3%
May 16, 2022	Astley-Sparke Philip	Chief Executive Officer	Sell	9,632	$14.59	$140,530.88	-0.7%	+42.1%	+27.3%
May 16, 2022	Love Colin72	Chief Operating Officer	Sell	6,324	$14.59	$92,267.16	-0.8%	+42.1%	+27.3%
Mar 16, 2022	Omega Fund Iv, L.P.81	10% Owner	Sale+OE	106,500	$15.55	$1,656,482.88	-0.6%	-8.4%	+23.6%
Nov 22, 2021	Omega Fund Iv, L.P.81	Director, 10% Owner	Sell	45,424	$34.58	$1,570,679.30	-0.3%	-52.5%	-41.2%
Nov 18, 2021	Omega Fund Iv, L.P.81	Director, 10% Owner	Sell	2,594	$33.50	$86,899.00	-	-47.5%	-43.1%

← PrevPage 5Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC